U.S. markets close in 3 hours 49 minutes

Phreesia, Inc. (PHR)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
24.97-0.98 (-3.78%)
As of 12:08PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close25.95
Bid24.91 x 900
Ask24.95 x 3000
Day's Range24.50 - 25.56
52 Week Range13.19 - 76.10
Avg. Volume452,773
Market Cap1.312B
Beta (5Y Monthly)0.71
PE Ratio (TTM)N/A
EPS (TTM)-3.08
Earnings DateDec 06, 2022 - Dec 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est32.92
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for PHR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Phreesia, Inc.
    Daily – Vickers Top Buyers & Sellers for 09/09/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    28 days agoArgus Research
View more
  • Zacks

    Can Phreesia (PHR) Climb 26% to Reach the Level Wall Street Analysts Expect?

    The average of price targets set by Wall Street analysts indicates a potential upside of 25.7% in Phreesia (PHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

  • Business Wire

    Phreesia Names Alexandra Beneville Vice President of Life Sciences Content Strategy

    WILMINGTON, Del., September 22, 2022--Phreesia, a leader in patient intake, outreach and activation, has named Alexandra Beneville as Vice President of Life Sciences Content Strategy. Beneville officially joined Phreesia on Aug. 1, 2022, from Phosphorus, a direct-to-consumer genomic testing company, where she had served as Vice President of Marketing since December 2021.

  • Business Wire

    Phreesia’s Zeeshan Butt Named to NQF’s MAP Clinician Workgroup

    WILMINGTON, Del., September 16, 2022--Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the National Quality Forum (NQF)’s Measure Applications Partnership (MAP) 2022-2023 Clinician Workgroup.